BCR-ABL TRANSCRIPT QUANTIFICATION

Measures the quantity of BCR-ABL transcripts in blood, which is used to assess the severity of chronic myelogenous leukemia (CML). It helps monitor the effectiveness of therapy and disease progression.

Also known asBcr-abl Transcript Quantification (philadelphia Chromosome) Bcr-abl Transcript Quantification (philadelphia Chromosome)

Available via

Home Collection, Lab Visit

Contains

9 parameters

Earliest reports in

2 Working Days

Test details
Preparations

No special preparations needed

Test included
BCR-ABL TRANSCRIPT QUANTIFICATION includes 9 parameters

  • Bcr-abl1 Copy Number
  • Abl1 Copy Number
  • Conversion Factor Is
  • Result % Ratio Is
  • Result Ncn Ratio

  • P210 (b3a2, B2a2) Major Transcript
  • P190 (e1a2) Minor Transcript
  • P230 (e19a2) Micro Transcript
  • Specimen Source

Test code

9892

Specimen vol. and vacutainer information
SpecimenVacutainerVolume
Bone MarrowOthers3 ML
Edta Whole BloodLavender Vacutainer3 ML

Specimen stability information

Bone Marrow, Edta Whole Blood

Specimen rejection criteria

Test run frequency

'

Turn around time

2 Working Days

Performing locations

Department

  • Advanced Molecular Diagnostics R&d

CPT and Loinc codes

BCR-ABL TRANSCRIPT QUANTIFICATION

6900